Inventor · disambiguated record
Daqing Sun
Also filed as: SUN DAQING
36 granted patents·24 pending applications·175 citations·filing 2002–2025
96Inventor score
Files withORIC PHARMACEUTICALS INC26AMGEN INC22POWERS JAY P5SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD5FRENKEL ALEXANDER DAVID1
Top patents by PatentIndex Score
60 records- 0196US11028120B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Jun 8, 2021·10 cites·30 claims
- 0295US12018043B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·6 cites·33 claims
- 0395US11130778B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Sep 28, 2021·8 cites·30 claims
- 0494US11530236B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·4 cites·25 claims
- 0593US11325938B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·9 cites·20 claims
- 0693US7132438B2Benzimidazole derivativesAMGEN INC·Filed 2002·Granted Nov 7, 2006·62 cites·29 claims
- 0792US7524848B2Diaza heterocyclic amide compounds and their usesAMGEN INC·Filed 2007·Granted Apr 28, 2009·24 cites·7 claims
- 0891US11129841B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·7 cites·20 claims
- 0990US10472387B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·2 cites·6 claims
- 1088US11377469B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 1188US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1288US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1387US12454544B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2024·Granted Oct 28, 2025·0 cites·9 claims
- 1487US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1586US11576922B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2021·Granted Feb 14, 2023·1 cites·41 claims
- 1686US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1785US11807658B2CD73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Granted Nov 7, 2023·1 cites·19 claims
- 1883US2025368677A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1980US7635774B2Benzimidazole derivativesAMGEN INC·Filed 2006·Granted Dec 22, 2009·3 cites·1 claims
- 2080US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2179US11124537B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·1 cites·23 claims
- 2279US7605289B2Benzamide derivatives and uses related theretoAMGEN INC·Filed 2006·Granted Oct 20, 2009·4 cites·42 claims
- 2378US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 2476US10723759B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2019·Granted Jul 28, 2020·0 cites·28 claims
- 2576US2023096870A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2676US2024124512A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2774US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2870US10836789B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·0 cites·30 claims
- 2969US2021017219A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3067US2022259253A1Cd73 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3167US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3265US2025368667A1Usp1 inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2023·Application pending·0 cites
- 3365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3464US2021379084A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3564US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3663US2010048565A1Benzimidazole derivativesFRENKEL ALEXANDER DAVID·Filed 2009·Application pending·0 cites
- 3761US7365075B2Aryl sulfonamide compounds and uses related theretoAMGEN INC·Filed 2004·Granted Apr 29, 2008·1 cites·46 claims
- 3861US2021395295A1Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3960US7834047B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2008·Granted Nov 16, 2010·0 cites·11 claims
- 4060US2025206763A1Enpp1 inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2023·Application pending·0 cites
- 4159US11110103B2Inhibitors of glucocorticoid receptorORIC PHARMACEUTICALS INC·Filed 2016·Granted Sep 7, 2021·0 cites·12 claims
- 4259US8637576B2Benzamide derivatives and uses related theretoPOWERS JAY P·Filed 2009·Granted Jan 28, 2014·0 cites·4 claims
- 4359US8138190B2Diaza heterocyclic amide compounds and their usesPOWERS JAY P·Filed 2009·Granted Mar 20, 2012·0 cites·5 claims
- 4458US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 4556US8765788B2Tricyclic inhibitors of hydroxysteroid dehydrogenasesPOWERS JAY P·Filed 2008·Granted Jul 1, 2014·0 cites·4 claims
- 4651US7495012B2Arylsulfonamides and uses related theretoAMGEN INC·Filed 2005·Granted Feb 24, 2009·0 cites·21 claims
- 4750US2024351997A1Novel parp7 inhibitor and use thereofSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2022·Application pending·0 cites
- 4849US2025009745A1Cdk inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2022·Application pending·0 cites
- 4949US2025042889A13clpro protease inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2022·Application pending·0 cites
- 5047US2021147472A1Solid forms and formulations comprising a glucocorticoid receptor antagonist and uses thereofORIC PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daqing Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →